These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 25634171

  • 1. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
    Watanabe Y, Suzuki S, Nishimura H, Murata KY, Kurashige T, Ikawa M, Asahi M, Konishi H, Mitsuma S, Kawabata S, Suzuki N, Nishino I.
    Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
    Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.
    Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
    [Abstract] [Full Text] [Related]

  • 6. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
    Carvalho AAS, Silva VGD, Vieira TF, Delgado PO, Corazini R, Feder D, Fonseca FLA.
    Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Autoimmune necrotising myopathy and HMGCR antibodies.
    Karunaratne K, Amiras D, Pickering MC, Hofer M, Viegas S.
    Pract Neurol; 2018 Apr; 18(2):151-155. PubMed ID: 29439058
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
    Shovman O, Gilburd B, Chayat C, Lazar AD, Amital H, Blank M, Bentow C, Mahler M, Shoenfeld Y.
    Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
    [Abstract] [Full Text] [Related]

  • 12. [Screening of autoantibodies associated with necrotizing myopathy among undiagnosed chronic myopathy].
    Kuru S, Suzuki S, Ogata K, Kobayashi M, Ishida C, Watanabe C, Matsumura T.
    Rinsho Shinkeigaku; 2017 Oct 27; 57(10):562-566. PubMed ID: 28954975
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy.
    Llansó L, Segarra-Casas A, Domínguez-González C, Malfatti E, Kapetanovic S, Rodríguez-Santiago B, de la Calle O, Blanco R, Dobrescu A, Nascimento-Osorio A, Paipa A, Hernandez-Lain A, Jou C, Mariscal A, González-Mera L, Arteche A, Lleixà C, Caballero-Ávila M, Carbayo Á, Vesperinas A, Querol L, Gallardo E, Olivé M.
    Neurol Neuroimmunol Neuroinflamm; 2024 Sep 27; 11(5):e200285. PubMed ID: 39106428
    [Abstract] [Full Text] [Related]

  • 15. Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.
    Drouot L, Allenbach Y, Jouen F, Charuel JL, Martinet J, Meyer A, Hinschberger O, Bader-Meunier B, Kone-Paut I, Campana-Salort E, Eymard B, Tournadre A, Musset L, Sibilia J, Marie I, Benveniste O, Boyer O, French Myositis Network [CN].
    Arthritis Res Ther; 2014 Feb 03; 16(1):R39. PubMed ID: 24484965
    [Abstract] [Full Text] [Related]

  • 16. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
    Merlant M, Fite C, Kottler D, Maisonobe L, Dossier A, Deschamps L, Descamps V.
    Ann Dermatol Venereol; 2019 Sep 03; 146(8-9):550-556. PubMed ID: 30929872
    [Abstract] [Full Text] [Related]

  • 17. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.
    Limaye V, Bundell C, Hollingsworth P, Rojana-Udomsart A, Mastaglia F, Blumbergs P, Lester S.
    Muscle Nerve; 2015 Aug 03; 52(2):196-203. PubMed ID: 25521389
    [Abstract] [Full Text] [Related]

  • 18. Statins and myositis: the role of anti-HMGCR antibodies.
    Selva-O'Callaghan A, Alvarado-Cardenas M, Marin A, Pinal-Fernandez I.
    Expert Rev Clin Immunol; 2015 Aug 03; 11(12):1277-9. PubMed ID: 26492593
    [Abstract] [Full Text] [Related]

  • 19. Spectrum of immune-mediated necrotizing myopathies and their treatments.
    Pinal-Fernandez I, Mammen AL.
    Curr Opin Rheumatol; 2016 Nov 03; 28(6):619-24. PubMed ID: 27607340
    [Abstract] [Full Text] [Related]

  • 20. Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the Disease.
    Szczesny P, Barsotti S, Nennesmo I, Danielsson O, Dastmalchi M.
    Front Immunol; 2022 Nov 03; 13():866701. PubMed ID: 35603214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.